Both in Pharmaceuticals
NextCure vs Briacell Therapeutics
Over the past year NXTC returned −45.5% and BCTX returned −73.4%; their daily moves had a correlation of 0.04.
NXTC −45.5% BCTX −73.4%Growth of $1, one year, split-adjusted
| Metric | NXTC | BCTX |
|---|---|---|
| Price | $6.53 | $3.31 |
| Market cap | $29.9M | $28.8M |
| Today | +2.92% | −5.43% |
| 1 month | +30.2% | −22.7% |
| 6 months | −29.2% | −20.8% |
| Year to date | −54.0% | −53.4% |
| 1 year | −37.0% | −75.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.1M | $20.5M |
| Dividend yield | — | — |
| Volatility (60d) | 114.2% | 76.1% |
| Short % of float | 8.4% | 9.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).